These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9708632)

  • 1. Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma.
    Rosenthal MA; Oratz R
    Am J Clin Oncol; 1998 Aug; 21(4):352-4. PubMed ID: 9708632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma.
    Triozzi PL; Walker MJ; Pellegrini AE; Dayton MA
    Cancer Invest; 1996; 14(4):293-8. PubMed ID: 8689422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
    Stadler WM; Kuzel T; Dumas M; Vogelzang NJ
    J Clin Oncol; 1998 May; 16(5):1820-5. PubMed ID: 9586896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer.
    Rinaldi DA; Lippman SM; Burris HA; Chou C; Von Hoff DD; Hong WK
    Anticancer Drugs; 1993 Feb; 4(1):33-6. PubMed ID: 8457712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
    Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
    J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma.
    Grignol VP; Olencki T; Relekar K; Taylor C; Kibler A; Kefauver C; Wei L; Walker MJ; Chen HX; Kendra K; Carson WE
    J Immunother; 2011; 34(6):509-15. PubMed ID: 21654521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma.
    Dhingra K; Papadopoulos N; Lippman S; Lotan R; Legha SS
    Invest New Drugs; 1993 Feb; 11(1):39-43. PubMed ID: 8349434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
    Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
    Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of metastatic melanoma treated with a combination of interferon alfa 2b, dacarbazine and nimustine.
    Gröhn P; Kumpulainen E; Nuortio L; Hakala T; Vuoristo MS; Korpela M; Heikkinen M; Salmi R; Jakobsson M; Numminen S
    Eur J Cancer; 1992; 28(2-3):441-3. PubMed ID: 1591060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
    Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
    Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer.
    Jacobs A; Gold P; Weiden P; Aboulafia D; Rudolph R; Picozzi V; Thompson J
    Cancer Invest; 2000; 18(5):417-21. PubMed ID: 10834025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
    Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
    Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.
    Sondak VK; Liu PY; Flaherty LE; Fletcher WS; Periman P; Gandara DR; Taylor SA; Balcerzak SP; Meyskens FL
    Cancer J Sci Am; 1999; 5(1):41-7. PubMed ID: 10188060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of highly purified human leukocyte interferon alpha and 13-cis-retinoic acid for the treatment of metastatic melanoma.
    Fierlbeck G; Schreiner T; Rassner G
    Cancer Immunol Immunother; 1995 Mar; 40(3):157-64. PubMed ID: 7728774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.
    Falkson CI; Ibrahim J; Kirkwood JM; Coates AS; Atkins MB; Blum RH
    J Clin Oncol; 1998 May; 16(5):1743-51. PubMed ID: 9586887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
    Hansson J; Aamdal S; Bastholt L; Brandberg Y; Hernberg M; Nilsson B; Stierner U; von der Maase H;
    Lancet Oncol; 2011 Feb; 12(2):144-52. PubMed ID: 21256809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
    Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
    Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Blessing JA; Nelson BE; Johnson GA; Fowler WC; Reid GC
    Am J Clin Oncol; 1998 Dec; 21(6):591-4. PubMed ID: 9856661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma.
    Gause BL; Sharfman WH; Janik JE; Curti BD; Steis RG; Urba WJ; Smith JW; Alvord WG; Longo DL
    Cancer Invest; 1998; 16(6):374-80. PubMed ID: 9679527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.